Greenwood Capital Associates LLC Biogen Inc. Transaction History

Greenwood Capital Associates LLC

$755 Million
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Mar 05, 2024	BUY	$222.59 - $267.94 $14,468 - $17,416	65 Added 0.34%	19,145 $4.95 Million
Q3 2023 Oct 18, 2023	SELL	$253.3 - $285.89 $1.59 Million - $1.8 Million	-6,282 Reduced 24.77%	19,080 $4.9 Million
Q2 2023 Aug 07, 2023	SELL	$275.25 - $318.06 $781,985 - $903,608	-2,841 Reduced 10.07%	25,362 $7.22 Million
Q1 2023 May 12, 2023	BUY	$256.56 - $292.34 $491,055 - $559,538	1,914 Added 7.28%	28,203 $7.84 Million
Q4 2022 Jan 26, 2023	SELL	$252.44 - $306.72 $139,346 - $169,309	-552 Reduced 2.06%	26,289 $0
Q3 2022 Nov 10, 2022	SELL	$194.69 - $268.46 $374,583 - $516,517	-1,924 Reduced 6.69%	26,841 $7.17 Million
Q2 2022 Aug 10, 2022	BUY	$187.54 - $223.02 $569,934 - $677,757	3,039 Added 11.81%	28,765 $5.87 Million
Q1 2022 May 10, 2022	BUY	$193.77 - $244.14 $4.98 Million - $6.28 Million	25,726 New	25,726 $5.42 Million
Q2 2019 Aug 13, 2019	SELL	$219.29 - $241.72 $3.97 Million - $4.38 Million	-18,102 Closed	0 $0
Q1 2019 May 03, 2019	BUY	$216.71 - $338.96 $137,610 - $215,239	635 Added 3.64%	18,102 $4.28 Million
Q4 2018 Feb 11, 2019	BUY	$278.5 - $352.75 $523,023 - $662,464	1,878 Added 12.05%	17,467 $5.26 Million
Q3 2018 Nov 13, 2018	BUY	$293.51 - $383.83 $250,070 - $327,023	852 Added 5.78%	15,589 $5.51 Million
Q2 2018 Aug 07, 2018	BUY	$257.52 - $306.91 $865,009 - $1.03 Million	3,359 Added 29.52%	14,737 $4.28 Million
Q1 2018 May 15, 2018	SELL	$260.13 - $367.91 $49,424 - $69,902	-190 Reduced 1.64%	11,378 $3.12 Million
Q4 2017 Feb 02, 2018	SELL	$307.64 - $344.58 $2,153 - $2,412	-7 Reduced 0.06%	11,568 $3.69 Million
Q3 2017 Nov 03, 2017	BUY	$281.15 - $329.69 $3.25 Million - $3.82 Million	11,575	11,575 $3.62 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$2.88 Billion
0.08% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.84 Billion
2.78% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.53 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.1M
Shares

$1.23 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.68M
Shares

$987 Million
0.83% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenwood Capital Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Greenwood Capital Associates LLC with notifications on news.

Account